Evaluation of bronchodilator responses in patients with "irreversible" emphysema.
about
Vital capacity and inspiratory capacity as additional parameters to evaluate bronchodilator response in asthmatic patients: a cross sectional studyComparison of spirometric changes in the response to bronchodilators of patients with asthma or chronic obstructive pulmonary disease.The confounding effects of thoracic gas compression on measurement of acute bronchodilator responseOutcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroidsPerformance enhancement in chronic obstructive pulmonary disease.Outcome measures for COPD treatments: a critical evaluation.Improved outcomes in patients with chronic obstructive pulmonary disease treated with salmeterol compared with placebo/usual therapy: results of a meta-analysis.The clinical importance of dynamic lung hyperinflation in COPD.A pilot study of inspiratory capacity and resting dyspnea correlations in exacerbations of COPD and asthmaNew physiological insights into dyspnea and exercise intolerance in chronic obstructive pulmonary disease patients.Pharmacological management of breathlessness in COPD: recent advances and hopes for the future.Impact of bronchodilator use on the prevalence of COPD in population-based samples.Efficiency of neural respiratory drive for the assessment of bronchodilator responsiveness in patients with chronic obstructive pulmonary disease: an exploratory study.The lungs need to be deflated: effects of glycopyrronium on lung hyperinflation in COPD patients.Lung hyperinflation and its reversibility in patients with airway obstruction of varying severity.Bronchodilation in COPD: beyond FEV1-the effect of albuterol on resistive and reactive properties of the respiratory system.Single dose of inhaled procaterol has a prolonged effect on exercise performance of patients with COPD.The Link between Reduced Inspiratory Capacity and Exercise Intolerance in Chronic Obstructive Pulmonary Disease.Response patterns to bronchodilator and quantitative computed tomography in chronic obstructive pulmonary disease.
P2860
Q34403827-2612B4AA-B568-4895-A18E-6558F80A1AB0Q34599761-4FAF0BB3-06BB-44FD-B1F6-354083CAFE57Q35855138-31A8F921-058A-48AC-B11E-B1246887BA4BQ35876509-B8FB22E1-CB0F-4935-857D-893366E1C906Q36309971-DB5AD2F0-43E8-4A2F-96BB-8099A10AE79EQ36602287-C451DB76-5512-4D00-96FB-0FE1C99C04CEQ36695412-53416F93-AC97-4FA6-AE26-A410587CF67FQ36760103-8EB71A44-DF46-4A2F-8F43-026E57A4D6D4Q37236604-C958D194-D71D-4F55-97E2-D213B0C45052Q38066983-1EDA9524-2F67-494A-B5FE-508D9A5CADD7Q38817813-0ECA706E-AA20-4321-8008-03C643D9A7F1Q39798721-8D913A13-E8CF-4006-974D-399066225774Q40556568-B29B2922-92C9-4344-962D-7DED44448A0CQ41908094-94C665A5-56A7-4B01-9E61-635BB8B1713FQ42776522-0D9F7265-451E-416A-90B3-74ACDD8167E6Q45998472-B562B74E-9178-4C57-A3C9-A7BAA0F5ACA1Q46522568-62EFB5F2-75A6-470F-9A19-EC83C244E3BBQ47923166-1D571C4F-83F4-4B4E-938B-AD43B5AE9245Q53186884-51D7CB28-ADDC-4799-89D4-906A491BD2A8
P2860
Evaluation of bronchodilator responses in patients with "irreversible" emphysema.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Evaluation of bronchodilator responses in patients with "irreversible" emphysema.
@en
Evaluation of bronchodilator responses in patients with "irreversible" emphysema.
@nl
type
label
Evaluation of bronchodilator responses in patients with "irreversible" emphysema.
@en
Evaluation of bronchodilator responses in patients with "irreversible" emphysema.
@nl
prefLabel
Evaluation of bronchodilator responses in patients with "irreversible" emphysema.
@en
Evaluation of bronchodilator responses in patients with "irreversible" emphysema.
@nl
P2093
P1476
Evaluation of bronchodilator responses in patients with "irreversible" emphysema.
@en
P2093
D E O'Donnell
P304
P356
10.1183/09031936.01.00216501
P577
2001-12-01T00:00:00Z